134 related articles for article (PubMed ID: 20345477)
21. Meta-analyses of the association between Chlamydia psittaci and ocular adnexal lymphoma and the response of ocular adnexal lymphoma to antibiotics.
Husain A; Roberts D; Pro B; McLaughlin P; Esmaeli B
Cancer; 2007 Aug; 110(4):809-15. PubMed ID: 17594698
[TBL] [Abstract][Full Text] [Related]
22. Long-term outcome and patterns of failure in primary ocular adnexal mucosa-associated lymphoid tissue lymphoma treated with radiotherapy.
Hashimoto N; Sasaki R; Nishimura H; Yoshida K; Miyawaki D; Nakayama M; Uehara K; Okamoto Y; Ejima Y; Azumi A; Matsui T; Sugimura K
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1509-14. PubMed ID: 21664061
[TBL] [Abstract][Full Text] [Related]
23. Orbital and ocular adnexal Mucosa-Associated Lymphoid Tissue (MALT) lymphomas: a single-center 10-year experience.
Smiljanic M; Milosevic R; Antic D; Andjelic B; Djurasinovic V; Todorovic M; Bila J; Bogdanovic A; Mihaljevic B
Med Oncol; 2013 Dec; 30(4):722. PubMed ID: 24026660
[TBL] [Abstract][Full Text] [Related]
24. Suggestion of response evaluation criteria in patients with ocular adnexal mucosa-associated lymphoid tissue lymphoma (OAML).
Jung SK; Paik JS; Jung SE; Park G; Choi BO; Oh JK; Park YG; Yang SW; Cho SG
Ann Hematol; 2015 Jul; 94(7):1185-93. PubMed ID: 25728714
[TBL] [Abstract][Full Text] [Related]
25. Periocular mucosa-associated lymphoid/low grade lymphomas: treatment with antibiotics.
Abramson DH; Rollins I; Coleman M
Am J Ophthalmol; 2005 Oct; 140(4):729-30. PubMed ID: 16226528
[TBL] [Abstract][Full Text] [Related]
26. Recent developments in nongastric mucosa-associated lymphoid tissue lymphoma.
Troch M; Kiesewetter B; Raderer M
Curr Hematol Malig Rep; 2011 Dec; 6(4):216-21. PubMed ID: 21808988
[TBL] [Abstract][Full Text] [Related]
27. Chlamydia-psittaci-eradicating antibiotic therapy in patients with advanced-stage ocular adnexal MALT lymphoma.
Ferreri AJ; Dognini GP; Ponzoni M; Pecciarini L; Cangi MG; Santambrogio G; Resti AG; De Conciliis C; Magnino S; Pasini E; Vicari N; Dolcetti R; Doglioni C
Ann Oncol; 2008 Jan; 19(1):194-5. PubMed ID: 18073219
[No Abstract] [Full Text] [Related]
28. Long-term survival outcomes of patients with primary ocular adnexal MALT lymphoma: A large single-center cohort study.
Liang Y; Fu RY; Liu XL; Liu XD; Piao YS; Ma JM; Wang L
Cancer Med; 2023 Feb; 12(3):2514-2523. PubMed ID: 35906828
[TBL] [Abstract][Full Text] [Related]
29. Radiotherapy for extranodal, marginal zone, B-cell lymphoma of mucosa-associated lymphoid tissue originating in the ocular adnexa: a multiinstitutional, retrospective review of 50 patients.
Uno T; Isobe K; Shikama N; Nishikawa A; Oguchi M; Ueno N; Itami J; Ohnishi H; Mikata A; Ito H
Cancer; 2003 Aug; 98(4):865-71. PubMed ID: 12910532
[TBL] [Abstract][Full Text] [Related]
30. Localized ocular adnexal mucosa-associated lymphoid tissue lymphoma treated with radiation therapy: a long-term outcome in 86 patients with 104 treated eyes.
Harada K; Murakami N; Kitaguchi M; Sekii S; Takahashi K; Yoshio K; Inaba K; Morota M; Ito Y; Sumi M; Suzuki S; Tobinai K; Uno T; Itami J
Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):650-4. PubMed ID: 24521680
[TBL] [Abstract][Full Text] [Related]
31. [The clinical features and outcomes in 21 patients with ocular adnexal mucosa-associated lymphoid tissue lymphoma].
Ning F; Ye J; Wei LQ; Li X; Wang JW
Zhonghua Nei Ke Za Zhi; 2012 Oct; 51(10):784-7. PubMed ID: 23290977
[TBL] [Abstract][Full Text] [Related]
32. The clinical characteristics and treatment results of ocular adnexal lymphoma.
Woo JM; Tang CK; Rho MS; Lee JH; Kwon HC; Ahn HB
Korean J Ophthalmol; 2006 Mar; 20(1):7-12. PubMed ID: 16768184
[TBL] [Abstract][Full Text] [Related]
33. Efficacy of chemotherapy as a first-line treatment in ocular adnexal extranodal marginal zone B-cell lymphoma.
Song EK; Kim SY; Kim TM; Lee KW; Yun T; Na II; Shin H; Lee SH; Kim DW; Khwarg SI; Heo DS
Ann Oncol; 2008 Feb; 19(2):242-6. PubMed ID: 17947227
[TBL] [Abstract][Full Text] [Related]
34. Feasibility of the TNM-based staging system of ocular adnexal extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma).
Lee SE; Paik JS; Cho WK; Choi BO; Lee SN; Jung SE; Park KS; Kang CS; Kim SH; Yang SW; Cho SG
Am J Hematol; 2011 Mar; 86(3):262-6. PubMed ID: 21328439
[TBL] [Abstract][Full Text] [Related]
35. Extranodal marginal zone B cell lymphoma of mucosa-associated lymphoid tissue type of the ocular adnexa: retrospective single institution review of 95 patients.
Lim SH; Kang M; Son J
Indian J Ophthalmol; 2011; 59(4):273-7. PubMed ID: 21666310
[TBL] [Abstract][Full Text] [Related]
36. Risk potentiality of frontline radiotherapy associated cataract in primary ocular adnexal mucosa-associated lymphoid tissue lymphoma.
Cho WK; Lee SE; Paik JS; Cho SG; Yang SW
Korean J Ophthalmol; 2013 Aug; 27(4):243-8. PubMed ID: 23908569
[TBL] [Abstract][Full Text] [Related]
37. [Chinese expert consensus on the diagnosis and management of ocular adnexal extranodal marginal zone mucosa-associated lymphoid tissue lymphoma (2023 edition)].
; ; ; ;
Zhonghua Zhong Liu Za Zhi; 2024 Apr; 46(4):296-303. PubMed ID: 38303512
[TBL] [Abstract][Full Text] [Related]
38. Ophthalmologic outcomes after chemotherapy and/or radiotherapy in non-conjunctival ocular adnexal MALT lymphoma.
Paik JS; Cho WK; Lee SE; Choi BO; Jung SE; Park GS; Kim SH; Yang SW; Cho SG
Ann Hematol; 2012 Sep; 91(9):1393-401. PubMed ID: 22543827
[TBL] [Abstract][Full Text] [Related]
39. High-dose clarithromycin is an active monotherapy for patients with relapsed/refractory extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT): the HD-K phase II trial.
Ferreri AJ; Sassone M; Kiesewetter B; Govi S; Scarfò L; Donadoni G; Raderer M
Ann Oncol; 2015 Aug; 26(8):1760-5. PubMed ID: 25935794
[TBL] [Abstract][Full Text] [Related]
40. The role of
Wang W; Ni X; Tang T; Wang J; Li Y; Song X
Br J Radiol; 2022 Feb; 95(1130):20210635. PubMed ID: 34919440
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
